#USA #Prague #BTL #EXOLASE ONE® #Erbium Laser

BTL's Innovative Leap in Laser Technology

In a significant advancement within the field of aesthetic medicine, BTL has officially launched its laser division, introducing the EXOLASE ONE®, the world’s first fused erbium laser system. This groundbreaking technology consolidates multiple erbium laser wavelengths into one singular beam, setting a new standard for facial rejuvenation treatments.

A New Era in Aesthetic Treatment

The EXOLASE ONE® system represents a tremendous step forward in aesthetic treatments, enabling practitioners to target the same area simultaneously, unlike traditional lasers that often require multiple devices. This novel interaction between the laser and the tissue leads to improved clinical efficacy, faster treatment speeds, and enhanced patient comfort.

Dr. Reha Yavuzer, a pioneering clinical researcher for this platform, expressed excitement about this innovation, highlighting how it integrates the capabilities of both ablative and non-ablative systems into a straightforward procedure that can treat the entire face in under 10 minutes while delivering outstanding results for patients.

From Vision to Reality

This milestone is a result of BTL’s robust research and development efforts, which have already produced several industry-leading innovations. CEO Tomas Schwarz stated, “This is a historic moment for BTL. We knew from the beginning that only a truly groundbreaking technology would allow us to build a real laser powerhouse,” emphasizing the feedback from leading clinical centers worldwide that guided the development of EXOLASE ONE®.

Set to be available globally in 2027 after an early-access program for selected key opinion leaders, EXOLASE ONE® will focus initially on aesthetic and dermatological applications. This new laser division will become BTL's sixth core business area, supplementing its existing domains in aesthetics, mental well-being, rehabilitation, cardiology, and robotics.

About BTL

Established in 1993, BTL has emerged as a leading manufacturer of medical and aesthetic devices, employing over 5,000 staff across more than 90 countries. The company has revolutionized the industry by providing advanced, non-invasive solutions for body shaping, skin tightening, facial rejuvenation, and more. Renowned products under BTL include EMSCULPT NEO®, EMFACE®, EMSELLA®, and EXOMIND®. For more information on BTL and its medical innovations, visit www.btlaesthetics.com.

As BTL embraces this new frontier in laser technology, the future of aesthetic treatment continues to evolve, promising to bring forth enhanced solutions that cater to the modern patient's needs.